Last reviewed · How we verify
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Botulinum Toxin-A injection | Botulinum Toxin-A injection | marketed | Neurotoxin; neuromuscular blocking agent | SNARE complex (specifically cleaves SNAP-25) | Neurology; Orthopedics; Aesthetics |
Therapeutic area mix
- Neurology; Orthopedics; Aesthetics · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ivo Pitanguy Institute · 1 shared drug class
- Lanzhou Institute of Biological Products Co., Ltd · 1 shared drug class
- University of Utah · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust:
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust pipeline updates — RSS
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust pipeline updates — Atom
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/robert-jones-and-agnes-hunt-orthopaedic-and-district-nhs-trust. Accessed 2026-05-17.